文献速递儿童消化与营养

胰酶替代治疗在儿童严重急性营养不良中的随机对照试验

Pancreatic Enzyme Replacement Therapy in Children with Severe Acute Malnutrition: A Randomized Controlled Trial.
PubMed 文献 · J Pediatr · 2017-09-11

该随机对照试验在马拉维纳入90例6-60月龄合并并发症的严重急性营养不良儿童,评估28天胰酶替代治疗(PERT)的获益。结果显示PERT未改善体重增长(13.7±9.0% vs 15.3±11.3%,P=.56),但干预组死亡率显著更低(18.6% vs 37.8%,P<.05),且出院速度更快(P=.02)。

要点

  • PERT未改善严重急性营养不良儿童的体重增长。
  • 干预组死亡率显著低于对照组(18.6% vs 37.8%)。
  • PERT组出院速度更快,但研究未针对死亡率差异设计检验效能。

核心结论

  • PERT不改善严重急性营养不良儿童的体重增长,但增加出院率。
  • PERT组死亡率更低,该发现需在更大样本中按水肿型和非水肿型分层进一步研究。
  • 严重急性营养不良的死亡与消化功能不良标志物相关。

研究设计与样本

  • 在马拉维Queen Elizabeth Central Hospital开展的随机对照试验,纳入90例6-60月龄合并并发症的严重急性营养不良儿童。
  • 所有儿童接受标准治疗,干预组额外接受28天PERT。

主要发现

  • PERT组与对照组体重增长无显著差异(13.7±9.0% vs 15.3±11.3%,P=.56)。
  • 入院时83.1%患者存在外分泌胰腺功能不全,住院期间粪便弹性蛋白酶-1水平升高,主要见于非水肿型严重急性营养不良(P<.01)。
  • 干预组死亡率显著低于对照组(18.6% vs 37.8%,P<.05),但研究未针对死亡率差异设计检验效能。
  • 死亡儿童入院时粪便脂肪酸分裂率较低。
  • PERT未改善外分泌胰腺功能不全,但PERT组出院速度更快(P=.02)。

临床怎么用

  • 对于合并并发症的严重急性营养不良儿童,PERT虽不改善体重增长,但可能与更低死亡率和更快出院相关。
  • 临床决策需结合个体情况,并注意该研究未针对死亡率差异设计检验效能。

局限性

  • 研究未针对死亡率差异设计检验效能。
  • 死亡率结果需在更大样本中按水肿型和非水肿型营养不良分层进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the benefits of pancreatic enzyme replacement therapy (PERT) in children with complicated severe acute malnutrition. STUDY DESIGN: We conducted a randomized, controlled trial in 90 children aged 6-60 months with complicated severe acute malnutrition at the Queen Elizabeth Central Hospital in Malawi. All children received standard care; the intervention group also received PERT for 28 days. RESULTS: Children treated with PERT for 28 days did not gain more weight than controls (13.7 ± 9.0% in controls vs 15.3 ± 11.3% in PERT; P = .56). Exocrine pancreatic insufficiency was present in 83.1% of patients on admission and fecal elastase-1 levels increased during hospitalization mostly seen in children with nonedematous severe acute malnutrition (P <.01). Although the study was not powered to detect differences in mortality, mortality was significantly lower in the intervention group treated with pancreatic enzymes (18.6% vs 37.8%; P < .05). Children who died had low fecal fatty acid split ratios at admission. Exocrine pancreatic insufficiency was not improved by PERT, but children receiving PERT were more likely to be discharged with every passing day (P = .02) compared with controls. CONCLUSIONS: PERT does not improve weight gain in severely malnourished children but does increase the rate of hospital discharge. Mortality was lower in patients on PERT, a finding that needs to be investigated in a larger cohort with stratification for edematous and nonedematous malnutrition. Mortality in severe acute malnutrition is associated with markers of poor digestive function. TRIAL REGISTRATION: ISRCTN.com: 57423639.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Bartels RH, Bourdon C, Potani I, et al. Pancreatic Enzyme Replacement Therapy in Children with Severe Acute Malnutrition: A Randomized Controlled Trial. J Pediatr. 2017. PMID: 28912050. doi:10.1016/j.jpeds.2017.07.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。